China Pharma Holdings Inc. (CPHI)

概要ニュース株価時系列ディスカッション予測株式分割

Relative Volume:

ネットキャッシュフロー:

China Pharma Holdings Inc. Stock (CPHI) Company Profile

China Pharma Holdings Inc.

Healthcare (1169)

86 898 6681 1730

No. 17, Jinpan Road, Second Floor, Haikou

CPHI's Discussions on Twitter

CPHI を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
CPHI China Pharma Holdings Inc.	0.208	4.00M	5.54M	-4.74M	-750.60K	-0.336
ZTS Zoetis Inc	160.46	71.85B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.08	45.58B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.06	44.58B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.74	19.18B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.60	13.67B	612.78M	-86.37M	-62.91M	-0.87

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2010-01-08	開始されました	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. (CPHI) 最新ニュース

China Pharma Holdings Inc. (CPHI) 財務データ

China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. Stock (CPHI) Company Profile

CPHI を他の銘柄と比較する

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

China Pharma Holdings Inc. (CPHI) 最新ニュース

Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services - PR Newswire

VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PR Newswire

InnoCare Pharma receives approval for CLL/SLL combination therapy trial in China - Yahoo

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com - Defense World

Is Pfizer Inc. (PFE) the Best Drug Stock to Buy Now? - Yahoo Finance

Why AbbVie Inc. (ABBV) Is One of the Best Drug Stocks to Buy Now - Yahoo Finance

U.S. investors, Big Pharma race to find new medicines in China - MSN

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - Quantisnow

China Pharma (NYSE:CPHI) Now Covered by StockNews.com - Defense World

Hong Kong Stock Exchange Companies List - Morningstar.com.au

Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace

China Pharma Holdings Inc (CPHI) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Post-Trade Analysis: China Pharma Holdings Inc (CPHI) Slides -7.63, Closing at 0.21 - The Dwinnex

Closing Bell Recap: International Paper Co (IP) Ends at 53.89, Reflecting a -3.47 Downturn - The Dwinnex

Big Pharma is staying quiet on Trump's China tariffs - Yahoo Finance

China Medical System Holdings Limited (HKG:867) insiders have significant skin in the game with 52% ownership - Simply Wall St

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by China Universal Asset Management Co. Ltd. - MarketBeat

China Universal Asset Management Co. Ltd. Acquires 8,018 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat

China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com - Defense World

Pharmaceuticals Wholesale and Distribution Market to grow by USD 896.5 Billion (2024-2028), driven by rising global pharmaceutical sales, Report on how AI is redefining market landscapeTechnavio - Yahoo Finance

China NT Pharma Group to Hold Extraordinary General Meeting for New Share Subscription Approval - TipRanks

China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com - Defense World

Ascentage Pharma Prices U.S. IPO At $17.25/ADS - RTTNews

Asia Hedge Funds Post Biggest Annual Returns Since the Pandemic - Bloomberg

Henlius Biotech shareholders reject take-private offer from China's Fosun - Reuters

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year - Yahoo Finance

‘The bar has risen’: China’s biotech gains push US companies to adapt - BioPharma Dive

Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update - Defense World

The top 10 biopharma M&A deals of 2024 - FiercePharma

Dry Eye Products Market Opportunities and Strategies to - GlobeNewswire

Li Ka-Shing-Backed Hutchmed Sells Stake in Unit for $608 Million - MSN

Barclays PLC Has $759,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World

StockNews.com Begins Coverage on China Pharma (NYSE:CPHI) - Defense World

China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 - Marketscreener.com

China Pharma Holdings, Inc. Rescinds Securities Purchase Agreement - Defense World

PetVivo Holdings, Inc. to Make Investor Presentations - Defense World

Keen Vision Acquisition Extends Business Combination PeriodKeen Vision Acquisition Corporation (NASDAQ: KVAC) has recently filed a Form 8-K with the Securities and Exchange Commission, announcing the extension of its business combination period. T - Defense World

AmpliTech Group Enters Securities Purchase Agreement with Institutional InvestorsWASHINGTON, D.C., December 24, 2024 – AmpliTech Group, Inc. (NASDAQ: AMPG) disclosed today in an 8-K filing with the Securities and Exchange Commission that it has - Defense World

Blackboxstocks Inc. Dismisses Turner, Stone & Company as Independent Registered Public Accounting Firm; Engages Victor Mokuolo CPA PLLC as ReplacementOn December 20, 2024, Blackboxstocks Inc. (NASDAQ: BLBX) made significant changes in its a - Defense World

The Glimpse Group Announces Closing of $7.29 Million OfferingWASHINGTON, D.C., December 23, 2024 – The Glimpse Group, Inc. (NASDAQ:VRAR) disclosed the finalization of a registered direct offering on December 23, 2024. The undertaking involved a - Defense World

Creative Medical Technology Holdings, Inc. Reports Amendment to Articles of Incorporation and Voting Results Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) filed a Form 8-K with the Securities and Exchange Commission on December 19, 20 - Defense World

Analysts Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $50.28 - Defense World

China Pharma Holdings, Inc. Successfully Conducts Annual Stockholders’ Meeting - Defense World

GlycoMimetics Receives Extension Notice from Nasdaq Regarding Minimum Bid Price ComplianceOn December 19, 2024, GlycoMimetics, Inc. (NASDAQ: GLYC) disclosed in an 8-K filing with the Securities and Exchange Commission that it had received an e - Defense World

**Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth** - Defense World

Wrap Technologies Reports Approval of Incentive Plan Amendment and Director Elections at Annual Meeting - Defense World

Financial Review: Autozi Internet Technology (Global) (NASDAQ:AZI) vs. Driven Brands (NASDAQ:DRVN) - Defense World

Aker BP ASA (OTCMKTS:AKRBF) Trading Down 1.7% – Here’s What Happened - Defense World

Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World

China Pharma Holdings Inc. (CPHI) 財務データ

収益

当期純利益

現金流量

EPS

CPHIに似た銘柄

Rhinebeck Bancorp Completes Balance Sheet Repositioning, Projects Earnings Growth - Defense World